Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism

Clinical Nephrology

Volumn 73, Issue 5, 2010, Pages 392-397

  Huang, W T ^a   Chau, T ^b   Wu, S T ^b   Lin, S H ^b  

^a ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Adrenalectomy; Hyperaldosteronism; Hyperkalemia; Hypokalemia; Renin

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; FLUDROCORTISONE; HYDROCORTISONE; POTASSIUM; POTASSIUM CHLORIDE; RENIN; SPIRONOLACTONE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASTHENIA; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DISEASE COURSE; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; FATIGUE; HORMONE INHIBITION; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERCHLOREMIC ACIDOSIS; HYPERKALEMIA; HYPOALDOSTERONISM; LABORATORY TEST; MALE; MUSCLE WEAKNESS; ORTHOSTATIC HYPOTENSION; PHYSICAL EXAMINATION; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIMARY HYPERALDOSTERONISM; SALT WASTING; SKIN TURGOR; T WAVE AMPLITUDE; URINALYSIS;

EID: 77951661969     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP73392     Document Type: Article

References (17)

1. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol. 2006; 2: 198-208. (Pubitemid 43787286)
2. Ganguly A. Primary aldosteronism. N Engl J Med. 1998; 339: 1828-1834.
3. Biglieri EG, Slaton PE Jr, Silen WS, Galante M, Forsham PH. Postoperative studies of adrenal function in primary aldosteronism. J Clin Endocrinol Metab. 1966; 26: 553-558.
4. Gadallah MF, Kayyas Y, Boules F. Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma. Am J Kidney Dis. 1998; 32: 160-163. (Pubitemid 28311885)
5. Taniguchi R, Koshiyama H, Yamauchi M et al. A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. Tohoku J Exp Med. 1998; 186: 215-223.
6. Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008; 19: 424-426.
7. Morimoto S, Takeda R, Murakami M. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism. J Clin Endocrinol. 1970; 31: 659-664.
8. Favia G, Lumachi F, Scarpa V, D'Amico DF. Adrenalectomy in primary aldosteronism: a longterm follow-up study in 52 patients.World J Surg. 1992; 16: 680-684.
9. Cox M, Sterns RH, Singer I. The defense against hyperkalemia: The role of insulin and aldosterone. N Engl J Med. 1978; 299: 525-531. (Pubitemid 9053820)
10. Otabe S, Muto S, Asano Y et al. Selective hypoaldosteronism in a patient with Sjögren's syndrome: insensitivity to angiotensin II. Nephron. 1991; 59: 466-470.
11. Douglas JG. Effects of high potassium diet on angiotensin II receptors and angiotensin-induced aldosterone production in rat adrenal glomerulosa cells. Endocrinology. 1980; 106: 983-990.
12. Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004; 89: 1045-1050.
13. Stowasser M, Klemm SA, Tunny TJ, Storie WJ, Rutherford JC, Gordon RD. Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol. 1994; 21: 319-322. (Pubitemid 24201226)
14. Rossi GP, Bernini G, Caliumi C et al. Aprospective study of the prevalence of primary aldosteronism in 1.125 hypertrensive patients. J Am Coll Cardiol. 2006; 48: 2293-2300.
15. Gagnon RF, Halperin ML. Possible mechanisms to explain the absence of hyperkalemia in Assison's disease. Nephrol Dial Transplant. 2001; 16: 1280-1284.
16. Horita Y, Inenaga T, Nakahama H et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis. 2001; 37: 884-889.
17. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol. 2007; 66: 607-618.